Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.

Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.

Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Kumari, Ashu
Andere auteurs: Burchert, Andreas (Prof Dr. ) (Thesis begeleider)
Formaat: Dissertation
Taal:Engels
Gepubliceerd in: Philipps-Universität Marburg 2011
Onderwerpen:
Imatinib mesylate
Chronisch-myeloische Leukämie
Imatinib mesilat
chronic mayeloid leukemia
Resistenz
Medizin
resistance
Medical sciences Medicine
Online toegang:PDF Full text
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

PDF Full text

Exemplaargegevens van
Plaatsingsnummer: urn:nbn:de:hebis:04-z2011-04590
Publicatiedatum: 2011-08-10
Datum der Annahme: 2011-07-26
Downloads: 45 (2024), 68 (2023), 63 (2022), 45 (2021), 80 (2020), 34 (2019), 25 (2018)
Lizenz: https://rightsstatements.org/vocab/InC-NC/1.0/
URL naar item: https://archiv.ub.uni-marburg.de/diss/z2011/0459
https://doi.org/10.17192/z2011.0459

Gelijkaardige items